secwatch.observer — SEC 8-K summary
======================================

Issuer:     Quoin Pharmaceuticals, Ltd. (QNRX)
CIK:        0001671502
Form:       8-K
Filed at:   2024-10-31T23:59:59+00:00
Accession:  0001104659-24-113085
Event type: other_material
Sentiment:  neutral
Materiality: 0.40
Item codes: 3.01
LLM model:  deepseek-v4-flash:cloud@v2

Quoin Pharma gets Nasdaq bid-price extension to April 28, 2025
--------------------------------------------------------------

- Nasdaq granted additional 180-day grace period until April 28, 2025 to regain $1.00 minimum bid price compliance.
- Company met all other Nasdaq Capital Market initial listing requirements; may effect reverse split if needed.
- If compliance not achieved by April 28, 2025, securities will be delisted, subject to appeal.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1671502/000110465924113085/0001104659-24-113085-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1671502/000110465924113085/tm2427194d1_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-24-113085

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer